Approval · Notice of Compliance 22874 · 2019
VIAGRA: Notice of Compliance 22874
Issued November 6, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22874
- Date
- November 6, 2019
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Kchange in the manufacturing process for the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIAGRA | Not yet assigned | — |
Medicinal ingredients
- SILDENAFIL CITRATE 25 MG per TAB
- SILDENAFIL CITRATE 50 MG per TAB
- SILDENAFIL CITRATE 100 MG per TAB